Indivior Pharmaceuticals, Inc. Stock London S.E.
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
London S.E.
23:35:04 24/07/2025 HKT
|
5-day change | 1st Jan Change | ||
| 1,238.00 GBX | +1.56% |
|
+5.27% | +20.90% |
| Market Cap | 4.23B 3.76B 3.51B 3.2B 6.03B 407B 6.11B 42.51B 16.46B 207B 15.88B 15.54B 666B | P/E 2026 * |
9.64x | P/E 2027 * | 8.73x |
|---|---|---|---|---|---|
| Enterprise Value | 4.22B 3.75B 3.5B 3.19B 6.01B 406B 6.09B 42.39B 16.41B 207B 15.84B 15.49B 664B | EV / Sales 2026 * |
3.17x | EV / Sales 2027 * | 2.62x |
| Free-Float |
98.18% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 week | +5.27% | ||
| 1 month | +20.78% | ||
| 3 months | +60.36% | ||
| 6 months | +29.91% | ||
| Current year | +20.90% |
| 1 week | 1,160 |  | 1,264 |
| 1 month | 975.5 | | 1,264 |
| 3 years | 554.83 | | 2,020 |
| 5 years | 335 | | 2,020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.56% | +5.27% | +49.52% | -20.18% | 4.23B | |
| -1.00% | -2.79% | +39.19% | +113.43% | 1,031B | |
| -2.23% | -4.17% | +39.42% | +67.19% | 638B | |
| -0.47% | -1.68% | +6.66% | +75.82% | 462B | |
| -1.00% | -2.51% | +60.07% | +40.68% | 359B | |
| -0.03% | -3.96% | +23.63% | +40.70% | 335B | |
| -1.58% | -0.76% | +13.50% | +26.44% | 273B | |
| -2.02% | -2.97% | -3.25% | +9.88% | 253B | |
| -2.37% | +1.49% | +38.06% | +54.75% | 228B | |
| -0.59% | -1.06% | +33.25% | +99.88% | 185B | |
| Average | -1.25% | -0.36% | +30.00% | +50.86% | 418.21B | |
| Weighted average by Cap. | -1.20% | -0.35% | +30.78% | +69.98% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.33B 1.18B 1.11B 1.01B 1.9B 128B 1.92B 13.38B 5.18B 65.31B 5B 4.89B 210B | 1.4B 1.24B 1.16B 1.06B 1.99B 135B 2.02B 14.06B 5.44B 68.63B 5.25B 5.14B 220B |
| Net income | 474M 421M 394M 359M 676M 45.66B 685M 4.77B 1.84B 23.26B 1.78B 1.74B 74.69B | 530M 471M 440M 401M 755M 51.03B 766M 5.33B 2.06B 25.99B 1.99B 1.95B 83.47B |
| Net Debt | -12.5M -11.1M -10.38M -9.46M -17.81M -1.2B -18.06M -126M -48.62M -613M -46.93M -45.91M -1.97B | -570M -506M -473M -431M -812M -54.88B -823M -5.73B -2.22B -27.95B -2.14B -2.09B -89.77B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
